Your session is about to expire
← Back to Search
Study Summary
This trial will test how treating insomnia in heavy drinkers can reduce alcohol consumption & prevent severe AUD. It will use CBT-I to reduce insomnia severity & alcohol consumption in heavy drinkers.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have been diagnosed with bipolar disorder, schizophrenia, or other disorders that affect your thoughts and perception of reality.You must be between the ages of 18 and 50.You have a significant medical or neurological condition.You have a history of addiction to drugs or alcohol, except for mild or moderate alcohol use disorder.You have a condition called obstructive sleep apnea, which affects your breathing while you sleep.
- Group 1: SHUTi Intervention
- Group 2: Web-Based Insomnia Education Program
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any opportunities to participate in this research at the moment?
"This particular trial, which was posted on December 1st 2022, is no longer accepting patients. According to clinicaltrials.gov, the study's most recent update had been made on November 17th 2022. Nevertheless, there are currently 374 other trials that remain open for enrollment."
Is it feasible for me to register in this clinical research?
"This clinical trial is accepting up to 100 patients with alcohol use disorder ranging from 18 to 50 years of age."
Is this research endeavor welcoming individuals who are 25 or older as participants?
"According to the trial's parameters, only those between 18-50 years old can be enrolled. For individuals below 18 and above 65 there are 35 respective trials available for them."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger